A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors (Q33924277)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors |
scientific article |
Statements
1 reference
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors (English)
1 reference
Ute Hoch
1 reference
Gayle S Jameson
1 reference
John T Hamm
1 reference
Glen J Weiss
1 reference
Carlos Alemany
1 reference
Stephen Anthony
1 reference
Michele Basche
1 reference
Ramesh K Ramanathan
1 reference
Mitesh J Borad
1 reference
Raoul Tibes
1 reference
Allen Cohn
1 reference
Ioana Hinshaw
1 reference
Robert Jotte
1 reference
Lee S Rosen
1 reference
Michael A Eldon
1 reference
Robert Medve
1 reference
Katrina Schroeder
1 reference
Erica White
1 reference
Daniel D Von Hoff
1 reference
7 November 2012
1 reference
1 reference
19
1 reference
268-278
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference